Incidence and Predictors of Secondary Failure to Biologic Therapy in Patients With Psoriatic Arthritis
Secondary failure to bDMARD is common in PsA and may be influenced by both disease- and therapy-related factors.
Authors
- Sheng Gao (ORCID: https://orcid.org/0000-0002-8622-5694)
- Ali Alhadri
- Fadi Kharouf (ORCID: https://orcid.org/0000-0002-3540-0341)
- Richard J. Cook (ORCID: https://orcid.org/0000-0002-1414-4908)
- Dafna D. Gladman
- Vinod Chandran (ORCID: https://orcid.org/0000-0002-8297-0275)
- Daniel Pereira (ORCID: https://orcid.org/0000-0003-0793-7800)
Institutions
- University Health Network (CA)
- University of Waterloo (CA)
- University of Toronto (CA)
- Arthritis and Rheumatism Associates (US)
- Krembil Foundation (CA)
- Krembil Research Institute
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3899/jrheum.2025-0518
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67